Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
211.3075 USD
−37.88 M USD
2.20 M USD
1.12 M
About Seelos Therapeutics, Inc.
Sector
Industry
CEO
Raj Mehra
Website
Headquarters
New York
Founded
1987
FIGI
BBG000BZ9W18
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SEELQ is 0.3001 USD — it has decreased by −39.37% in the past 24 hours. Watch Seelos Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Seelos Therapeutics, Inc. stocks are traded under the ticker SEELQ.
SEELQ stock has fallen by −58.32% compared to the previous week, the month change is a −74.78% fall, over the last year Seelos Therapeutics, Inc. has showed a −100.00% decrease.
SEELQ stock is 88.82% volatile and has beta coefficient of 1.91. Track Seelos Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Seelos Therapeutics, Inc. there?
Today Seelos Therapeutics, Inc. has the market capitalization of 337.35 K, it has decreased by −8.35% over the last week.
Yes, you can track Seelos Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Seelos Therapeutics, Inc. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
SEELQ net income for the last quarter is 1.71 M USD, while the quarter before that showed −2.66 M USD of net income which accounts for 164.19% change. Track more Seelos Therapeutics, Inc. financial stats to get the full picture.
No, SEELQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 16.00 employees. See our rating of the largest employees — is Seelos Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Seelos Therapeutics, Inc. EBITDA is −29.75 M USD, and current EBITDA margin is −1.84 K%. See more stats in Seelos Therapeutics, Inc. financial statements.
Like other stocks, SEELQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Seelos Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Seelos Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Seelos Therapeutics, Inc. stock shows the sell signal. See more of Seelos Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.